abstract |
The invention relates to quinoline / quinoxaline compounds that inhibit the activity of platelet-secreted growth factor and / or p56ltyrosine kinase, to pharmaceutical compositions comprising the compounds, and to their use in medicine for the treatment of patients suffering from cell differentiation, proliferation, production of an extracellular substance or secretion of a mediator and / or activation and proliferation of T cells. |